Announcement

Collapse
No announcement yet.

Omicron now

Collapse
This topic is closed.
X
X
  • Filter
  • Time
  • Show
Clear All
new posts

    'Among 1274 outpatients with documented SARS-CoV-2 infection 7.6% were prescribed hydroxychloroquine. In a 1067 patient propensity matched cohort, 21.6% with outpatient exposure to hydroxychloroquine were hospitalized, and 31.4% without exposure were hospitalized.

    In this retrospective observational study of SARS-CoV-2 infected non-hospitalized patients hydroxychloroquine exposure was associated with a decreased rate of subsequent hospitalization. '

    Comment


      Originally posted by Madison boxing View Post
      'Among 1274 outpatients with documented SARS-CoV-2 infection 7.6% were prescribed hydroxychloroquine. In a 1067 patient propensity matched cohort, 21.6% with outpatient exposure to hydroxychloroquine were hospitalized, and 31.4% without exposure were hospitalized.

      In this retrospective observational study of SARS-CoV-2 infected non-hospitalized patients hydroxychloroquine exposure was associated with a decreased rate of subsequent hospitalization. '
      Wanna post the source homeboy?

      Comment


        Originally posted by Dakuwaqa View Post

        Wanna post the source homeboy?


        Comment


          "Meta-analysis of 15 trials found that ivermectin reduced risk of death compared with no ivermectin (average risk ratio 0.38, 95% confidence interval 0.19–0.73; n = 2438; I2 = 49%; moderate-certainty evidence). This result was confirmed in a trial sequential analysis using the same DerSimonian–Laird method that underpinned the unadjusted analysis. This was also robust against a trial sequential analysis using the Biggerstaff–Tweedie method.

          Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally."

          Comment


            Originally posted by Madison boxing View Post


            "QTc prolongation events occurred in 2% of patients prescribed hydroxychloroquine with no reported arrhythmia events among those with data available."

            Comment


              "The study found that patients with Covid-19 treated in hospital who “received ivermectin early reported substantial recovery” and that there was “a substantial improvement and reduction in mortality rate in ivermectin treated groups” by 90%.

              But the drug’s promise as a treatment for the virus is in serious doubt after the Elgazzar study “due to ethical concerns”. Research Square did not outline what those concerns were."

              Comment


                these people go through these ****ing studies with a fine tooth comb when it doesnt support the big pharma agenda, 'study isnt valid because the investigator spelt someone name wrong' or some bull****. youve got patients in UK smuggling these drugs in via teddy bears to try and get the treatment they desperately need. the drugs are safe, if people want to try them when theyve got nothing to lose, ****ing let them!!!!!

                Comment


                  Originally posted by Madison boxing View Post
                  "The study found that patients with Covid-19 treated in hospital who “received ivermectin early reported substantial recovery” and that there was “a substantial improvement and reduction in mortality rate in ivermectin treated groups” by 90%.

                  But the drug’s promise as a treatment for the virus is in serious doubt after the Elgazzar study “due to ethical concerns”. Research Square did not outline what those concerns were."
                  "The paper’s irregularities came to light when Jack Lawrence, a master’s student at the University of London, was reading it for a class assignment and noticed that some phrases were identical to those in other published work. When he contacted researchers who specialize in detecting fraud in scientific publications, the group found other causes for concern, including dozens of patient records that seemed to be duplicates, inconsistencies between the raw data and the information in the paper, patients whose records indicate they died before the study’s start date, and numbers that seemed to be too consistent to have occurred by chance."



                  They had dead people in the study.

                  Comment


                    Originally posted by Madison boxing View Post
                    these people go through these ****ing studies with a fine tooth comb when it doesnt support the big pharma agenda, 'study isnt valid because the investigator spelt someone name wrong' or some bull****. youve got patients in UK smuggling these drugs in via teddy bears to try and get the treatment they desperately need. the drugs are safe, if people want to try them when theyve got nothing to lose, ****ing let them!!!!!
                    When the study has patients that died before the study began, i think it's safe to say the study is flawed.

                    Comment


                      I'd bet there's some nurses and docs that could use this PPE. 10 million dollars worth.

                      Comment

                      Working...
                      X
                      TOP